What are the contact precautions for individuals with shingles (varicella-zoster virus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contact Precautions for Shingles (Varicella-Zoster Virus)

Patients with shingles (herpes zoster) require airborne and contact precautions until all lesions are dry and crusted. 1

Infection Control Measures for Shingles

Standard Precautions

  • All patients with shingles require standard precautions including proper hand hygiene and appropriate personal protective equipment 1

Specific Isolation Requirements

  • For immunocompetent patients with localized herpes zoster:

    • Standard precautions with complete covering of the lesions 1
    • No negative air-flow room required for localized disease in immunocompetent hosts 1
  • For patients with disseminated herpes zoster or immunocompromised patients with herpes zoster:

    • Airborne precautions (negative air-flow rooms) 1
    • Contact precautions 1
    • For immunocompromised patients with localized herpes zoster, maintain these precautions until disseminated infection is ruled out 1
    • If negative air-flow rooms are not available, patients should be isolated in closed rooms and should not have contact with persons without evidence of immunity to varicella 1

Duration of Precautions

  • Precautions should be maintained until all lesions are dry and crusted 1
  • This typically takes 4-7 days after rash onset in immunocompetent hosts 1
  • May take longer in immunocompromised patients 2

Healthcare Personnel Considerations

Staff Assignment

  • Only healthcare personnel with evidence of immunity to varicella should care for patients with confirmed or suspected varicella or herpes zoster 1
  • Evidence of immunity includes:
    • Documentation of 2 doses of varicella vaccine 1
    • Laboratory evidence of immunity or laboratory confirmation of disease 1
    • Birth in the United States before 1980 (for non-healthcare personnel only) 1
    • Diagnosis or verification of a history of varicella or herpes zoster by a healthcare provider 1

Post-Exposure Management

  • Exposure to VZV is defined as close contact with an infectious person, such as close indoor contact or face-to-face contact 1
  • Healthcare personnel who have received 2 doses of vaccine and are exposed to VZV should be monitored daily during days 8-21 after exposure for fever, skin lesions, and systemic symptoms 1
  • Unvaccinated healthcare personnel without evidence of immunity who are exposed to VZV should be furloughed during days 8-21 after exposure 1
  • Post-exposure vaccination is recommended for susceptible healthcare personnel 1

Special Populations

Immunocompromised Patients

  • Immunocompromised patients with shingles often develop more severe disease lasting up to two weeks 3
  • Skin lesions are typically more numerous and may have a hemorrhagic base 3
  • Higher risk for cutaneous dissemination and visceral involvement 3
  • Require more stringent isolation precautions as noted above 1

HIV-Infected Individuals

  • May have two or more dermatomes involved 3
  • Recurrences of shingles can occur more frequently 3
  • No specific differences in isolation precautions compared to other immunocompromised hosts 2

Transmission Risk and Prevention

  • Shingles is caused by reactivation of latent varicella-zoster virus 4
  • Individuals with shingles may be contagious to susceptible children due to virus particles in vesicle fluid 3
  • Transmission occurs through direct contact with lesions or inhalation of aerosols from vesicular fluid 1
  • No preventive measures are currently available to prevent shingles itself 1
  • Household contacts of susceptible individuals should be vaccinated against VZV if they have no history of chickenpox and are seronegative for HIV 1

Common Pitfalls in Shingles Management

  • Failing to recognize that localized zoster in immunocompromised patients requires airborne and contact precautions until disseminated infection is ruled out 1
  • Not maintaining precautions until all lesions are completely dry and crusted 1
  • Allowing healthcare personnel without evidence of immunity to care for patients with shingles 1
  • Overlooking the potential for transmission to susceptible individuals, especially pregnant women and immunocompromised patients 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Varicella Zoster Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Varicella-zoster virus.

Clinical microbiology reviews, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.